Zanubrutinib-d5

SKU: orb2280686

Description

Zanubrutinib-d5 (BGB-3111-d5) is a deuterated derivative of the Bruton's tyrosine kinase (BTK) inhibitor zanubrutinib, designed for research use. This orally bioavailable small molecule is employed in pharmacokinetic and metabolic studies, supporting in vitro and in vivo research on B-cell malignancies such as chronic lymphocytic leukemia and mantle cell lymphoma.

Research Area

Pharmacology & Drug Discovery

Key Properties

• MW: 476.58
• Purity: >99.99% (May vary between batches)
• Formula: C₂₇H₂₉N₅O₃
• SMILES: O=C(N)C1=C2NCC[C@@H](C3CCN(C(C=C)=O)CC3)N2N=C1C4=CC=C(OC5=C([2H])C([2H])=C([2H])C([2H])=C5[2H])C=C4
• Target: BTK

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Compound Identifiers

PubChem CID

162640415